BRUSSELS (Reuters) – The European Union is not interested in buying possible COVID-19 vaccines through an initiative co-led by the World Health Organization, as it considers it to be slow and high-cost, two EU sources told Reuters, noting that the bloc was in talks with drug makers for vaccines cheaper …
Read More »
(Reuters) – The United States government has set a benchmark for the price of the COVID-19 vaccine in a $ 2 billion deal announced Wednesday with Pfizer Inc (PFE.N) and the German biotechnology BioNTech SE (22UAy.F) which will likely pressure other manufacturers to set similar prices, industry analysts told Reuters. …
Read More »
(Reuters) – Moderna Inc’s shares fell nearly 10% after losing a bid to invalidate a US patent owned by Arbutus Biopharma that represents a potential obstacle to Moderna’s efforts to develop next-generation vaccines, including a coronavirus vaccine. . FILE PHOTO: A sign marks the headquarters of Moderna Inc, which is …
Read More »
(Reuters) – The United States government has set a benchmark for the price of the COVID-19 vaccine in a $ 2 billion deal announced Wednesday with Pfizer Inc (PFE.N) and the German biotechnology BioNTech SE (22UAy.F) which will likely pressure other manufacturers to set similar prices, industry analysts told Reuters. …
Read More »
FILE PHOTO: Mike Ryan, Executive Director of the World Health Organization (WHO) attends a press conference on the Ebola outbreak in the Democratic Republic of the Congo at the United Nations in Geneva, Switzerland, May 3, 2019 REUTERS / Denis Balibouse GENEVA / ZURICH (Reuters) – Researchers are making “good …
Read More »